In early 2020, investigated REVIV as part of a larger investigation into the social media marketing of IV therapies, which found more than 40 clinics, including REVIV, using deceptive COVID-19 prevention and treatment claims in violation of federal law. REVIV had previously been warned by the FTC for making unsubstantiated coronavirus prevention and treatment claims.